Surgical resection of liver non-small cell lung cancer metastasis: A dual weapon?

Lung Cancer

Volumn 70, Issue 2, 2010, Pages 221-222

  Ileana, Ecaterina ^a   Greillier, Laurent ^a   Moutardier, Vincent ^a   Barlesi, F ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Liver metastases; Liver resection; Non small cell lung cancer; Surgery

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; BEVACIZUMAB; CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FLUORODEOXYGLUCOSE F 18; GEFITINIB; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; DIARRHEA; DRUG ERUPTION; FEMALE; HUMAN; LIVER METASTASIS; LIVER RESECTION; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; PARTIAL HEPATECTOMY; POINT MUTATION; PRIORITY JOURNAL;

EID: 77957017547     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.08.010     Document Type: Article

References (8)

1. Sarmiento J.M., Que F.G. Hepatic surgery for metastases from neuroendocrine tumors. Surg Oncol Clin N Am 2003, 12:231-242.
2. Ercolani G., Grazi G.L., Ravaioli M., Ramacciato G., Cescon M., Varotti G., et al. The role of liver resections for noncolorectal, nonneuroendocrine metastases: experience with 142 observed cases. Ann Surg Oncol 2005, 12:459-466.
3. O'Rourke T.R., Tekkis P., Yeung S., Fawcett J., Lynch S., Strong R., et al. Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol 2008, 15:207-218.
4. Ercolani G., Ravaioli M., Grazi G.L., Gescon M., et al. The role of liver resections for metastases from lung carcinoma. HPB 2006, 8:114-115.
5. Pfannschmidt J., Dienemann H. Surgical treatment of oligometastatic non-small cell lung cancer. Lung Cancer 2010, 69(3):251-258.
6. Grassetto G., Fornasiero A., Bonciarelli G. Additional value of FDG-PET/CT in management of " solitary" liver metastases: preliminary results of a prospective multicenter study. Mol Imaging Biol 2010, 12(2):139-144.
7. Wu M., Zhao J., Song S.W., Zhuo M., Wang X., Bai H., et al. EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer. Lung Cancer 2010, 67(3):343-347.
8. Laurent C., Rullier E., Feyler A., Masson B., Saric J. Resection of noncolorectal and nonneuroendocrine liver metastases: late metastases are the only chance of cure. World J Surg 2001, 25:1532-1536.